ADAM10 and hepatocellular carcinoma: Xu et al. found that miRNA-451a, delivered via human UC-MSC-Exos, inhibited epithelial–mesenchymal transition (EMT)-related proteins and paclitaxel resistance, promoting apoptosis in HCC cells by targeting ADAM10 [134] BM-MSCs can integrate into tumor tissues.